ST4 | Office of Inspector General, "Audit of the Army’s Integrated Visual Augmentation System," report DODIG-2022-085, April 20, 2022 (online report page). Verbatim What We Found and What We Recommend excerpts. The $21.88 billion is the maximum exposure described by the inspector general, not an amount paid or obligated. This source was not public at the 2021 decision date.

"Army testing officials assessed user acceptance from Soldiers who used IVAS during various operational tests and used the results of those surveys to make changes to the system. However, IVAS program officials did not define minimum user acceptance levels to determine whether IVAS would meet user needs. This occurred because Army policy did not require program officials to define suitable user acceptance levels. Procuring IVAS without attaining user acceptance could result in wasting up to $21.88 billion in taxpayer funds to field a system that Soldiers may not want to use or use as intended."

"We recommend that the Program Executive Officer Soldier define clear measures of user acceptance levels to meet user needs before Soldier Touch Point 5 testing of IVAS. In addition, we recommend that the Assistant Secretary of the Army (Acquisition, Logistics, and Technology), as the decision authority for IVAS, verify whether the Program Executive Office Soldier meets established user acceptance measures and addresses Soldier identified issues before IVAS production."

ST5 | Director, Operational Test & Evaluation, FY2022 Annual Report, "Integrated Visual Augmentation System (IVAS)," printed pp. 108-110, released January 2023. Verbatim excerpts. The office's report identifies the operational demonstration as May-June 2022. Testing results were not available at the 2021 decision date.

"The Army conducted an Operational Demonstration (Ops Demo) in May - June 2022 to support a production and rapid fielding decision. The Integrated Visual Augmentation System (IVAS) 1.0 did not demonstrate improvements to deficiencies identified during previous IVAS Capability Set (CS) 4 testing."

"The IVAS 1.2 variant will be the full-rate production system, incorporating an improved form factor within 24 months."

"In the Ops Demo, the infantry company was more successful accomplishing their operational missions with their current equipment than with IVAS 1.0. Soldiers hit fewer targets and engaged targets more slowly with IVAS 1.0 than with their current equipment on the buddy team live fire range."

"The majority of soldiers reported at least one symptom of physical impairment to include disorientation, dizziness, eyestrain, headaches, motion sickness and nausea, neck strain and tunnel vision."

"IVAS 1.0 MTBSA reliability metric declined during Ops Demo compared to IVAS CS4 EV2 in STP 4."

ST6 | Congress, Consolidated Appropriations Act, 2023, Division C explanatory statement, December 20, 2022, procurement table Night Vision Devices line 79. Verbatim table lines below; amounts in thousands of dollars. These lines are for the whole Night Vision Devices account, NOT an enacted IVAS procurement appropriation. The IVAS-specific request is the sum of the reduction and transfer.

"79 NIGHT VISION DEVICES                                                                   424,253    334,229"
"     IVAS program reduction                                                                         -360,024"
"     Transfer remaining IVAS funding to ROTE.A line 58                                               -40 ,000"
"     Program increase - ENVG-8                                                                       300,000"
"     Program increase - laser target locator module                                                   10,000"
